L2T1 Stock Chart & Stats
€5.20
-€0.15(-2.75%)
At close: 4:00 PM EDT
€5.20
-€0.15(-2.75%)
Day’s Range― - ―
52-Week Range€3.20 - €10.40
Previous CloseN/A
Volume0.00
Average Volume (3M)9.00
Market Cap
€67.42M
Enterprise Value€73.31M
Total Cash (Recent Filing)€14.92M
Total Debt (Recent Filing)€9.87M
Price to Earnings (P/E)14.9
Beta>-0.01
Next Earnings
Nov 04, 2026EPS Estimate
0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.40
Shares Outstanding12,589,444
10 Day Avg. Volume0
30 Day Avg. Volume9
Financial Highlights & Ratios
PEG Ratio-0.31
Price to Book (P/B)2.33
Price to Sales (P/S)0.43
P/FCF Ratio11.73
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€5.34Price Target Upside2.73% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)0.25
Revenue Forecast (FY)€144.92M
Bulls Say, Bears Say
Bulls Say
Recurring Revenue And RetentionSubscription revenue above 75% of Q4 total, alongside improved retention, gives LifeVantage a recurring demand base within its consultant-led model. This can make revenue more predictable, support customer lifetime value, and provide a stronger platform for recovery efforts over the next several quarters.
High Gross Margin ProfileA gross margin near 78% indicates strong product-level economics and meaningful room to fund commissions, selling expenses, innovation, and customer acquisition. Although volume has weakened, this margin structure gives management an economic base from which operational improvements can restore profitability.
Conservative Balance Sheet And Cash GenerationPositive operating and free cash flow, combined with modest leverage, gives LifeVantage flexibility to maintain operations and fund targeted initiatives without relying heavily on external financing. This balance-sheet resilience can help the company manage volatility while pursuing its turnaround and capital-return priorities.
Bears Say
Broad-based Revenue ContractionDeclines across both major geographic regions indicate that weakness is broad rather than isolated to one market. Fewer orders and lower average order size can reduce consultant productivity and customer engagement, making revenue recovery dependent on successfully rebuilding demand and improving the consumer proposition.
Profitability CompressionFalling adjusted EBITDA and a lower margin reduce the earnings cushion available to absorb further volume pressure or cost increases. With net margins already thin, continued profitability compression could constrain reinvestment, weaken operating leverage, and make sustained earnings recovery more difficult.
Leadership Transition And Limited GuidanceThe CEO transition and absence of formal FY2027 guidance increase uncertainty around the timing and scale of the company’s recovery plan. Reduced visibility can complicate operating and capital-allocation decisions while new brand, digital, and operational priorities are being implemented.
LifeVantage News
L2T1 FAQ
What was LifeVantage Corp’s price range in the past 12 months?
LifeVantage Corp lowest stock price was €3.20 and its highest was €10.40 in the past 12 months.
What is LifeVantage Corp’s market cap?
LifeVantage Corp’s market cap is €67.42M.
When is LifeVantage Corp’s upcoming earnings report date?
LifeVantage Corp’s upcoming earnings report date is Nov 04, 2026 which is in 24 days.
How were LifeVantage Corp’s earnings last quarter?
LifeVantage Corp released its earnings results on Aug 27, 2026. The company reported €0.095 earnings per share for the quarter, missing the consensus estimate of €0.099 by -€0.004.
Is LifeVantage Corp overvalued?
According to Wall Street analysts LifeVantage Corp’s price is currently Undervalued.
Does LifeVantage Corp pay dividends?
LifeVantage Corp does not currently pay dividends.
What is LifeVantage Corp’s EPS estimate?
LifeVantage Corp’s EPS estimate is 0.05.
How many shares outstanding does LifeVantage Corp have?
LifeVantage Corp has 12,589,444 shares outstanding.
What happened to LifeVantage Corp’s price movement after its last earnings report?
LifeVantage Corp reported an EPS of €0.095 in its last earnings report, missing expectations of €0.099. Following the earnings report the stock price went down -8.784%.
Which hedge fund is a major shareholder of LifeVantage Corp?
Currently, no hedge funds are holding shares in DE:L2T1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
LifeVantage Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
€5.34 (2.73% Upside)
€5.34 (2.73% Upside)
Blogger Sentiment
Neutral
DE:L2T1 Sentiment 100%
Sector Average 64%
Sector Average 64%
Insider Transactions
Sold Shares
Worth €56.9K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-34.04%
12-Months-Change
Fundamentals
Return on Equity
15.25%
Trailing 12-Months
Asset Growth
-13.68%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
LifeVantage Corp
LifeVantage Corporation (LFVN) specializes in the development, manufacture, and distribution of a diverse portfolio of health, wellness, and personal care products. Its offerings encompass nutrigenomic activators (designed to influence genetic expression), a broad array of dietary supplements, cognitive enhancers (nootropics), gut health support (pre- and pro-biotics), weight management solutions, and various personal care items spanning skin care, hair care, bath and body, and targeted relief. The company's product lineup features well-known brands such as Protandim, a series of scientifically validated dietary supplements. Specific examples include LifeVantage Omega+, a blend of DHA/EPA Omega-3s, Omega-7s, and Vitamin D3; LifeVantage ProBio, designed for digestive wellness; the PhysIQ brand for weight management; Petandim, tailored to reduce oxidative stress in dogs; and Axio energy drink mixes. Under the TrueScience brand, LifeVantage also provides anti-aging skincare (e.g., facial cleansers, perfecting lotions, eye serums, creams), hair care solutions (e.g., invigorating shampoos, nourishing conditioners, scalp serums), and an assortment of bath and body products (e.g., body lotion, wash, butter, deodorant) and targeted relief items (e.g., soothing balm, body rub). Distribution occurs through both its proprietary website and an extensive network of independent distributors. LifeVantage maintains a significant international presence, with operations spanning numerous global territories including the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, Singapore, and China. The corporation's headquarters are situated in Lehi, Utah.
L2T1 Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Negative
The call presented a mixed picture: the company retains meaningful strengths — a high recurring revenue mix (>75%), attractive gross margins near 78%, a debt-free balance sheet, positive cash from operations, ongoing buybacks and a dividend, and an incoming CEO with a targeted growth agenda — but these positives are outweighed by pronounced headwinds including a 23.1% year-over-year revenue decline, sequential revenue contraction, regional revenue weakness (Americas down 24.8%), reduced net income and adjusted EBITDA margins, higher operating cost pressures (inventory obsolescence, shipping), and a reduced cash balance. Management is focused on brand, consumer relevance, digital investments and operational improvements, but near-term uncertainty remains and the company withheld FY2027 guidance while implementing its strategic plan.View all DE:L2T1 earnings summariesL2T1 Stock 12 Month Forecast
Average Price Target
€5.34
▲(2.73% Upside)












